Development of new environment friendly insecticides against malaria mosquito

Use of pesticides as a preventive measure is still the most important element in the integrated management approach to malaria and other vector-borne disease parasitoses. In this project, new insecticides with enhanced selectivity to insects and not toxic to mammals and other animal species will be developed. Twenty new acetylcholinesterase (AChE, EC 3.1.1.7) inhibitors, which will covalently bond to the insect specific cysteine, will be prepared. This cysteine is located at the rim of active side in insect and is mutated to phenylalanine in other species. In this project, the synthesis of novel compounds and the structure-biological activity relationship (SAR) evaluation will be performed. Then, selection of the best insecticide candidates and their in vivo safety validation will be carried out and subsequent patent protection before commercialization will be applied.

Project details

Insecticide Resistance
Product Development

Jan 2016 — Dec 2019

$263,277

Czechia